laitimes

CCTV's "Gold Medal New Brand" visited Yangtze River Pharmaceutical Group to witness the modern butterfly changes of traditional Chinese medicine

"This city is not very big, but it has a great deal of earthly happiness." More than 700 years ago, Marco · Polo passed through here, glimpsing and leaving admiration. This healthy city and happy state is writing a new chapter with wisdom and innovation. At present, "summer health" has become a hot word on the Internet, and traditional Chinese medicine teas such as black plum soup and Qinghuo tea have become a fashion chased by young people. Data shows that the scale of China's health and wellness market will exceed one trillion yuan in 2023, and the traditional Chinese medicine industry is booming.

In 2023, the planting scale of traditional Chinese medicinal materials in Taizhou will reach more than 30,000 hectares, benefiting 100,000 planting farmers, driving an increase of 600 million yuan, and refreshing the new business card of Taizhou's traditional Chinese medicine industry. In Taizhou, more than 70 national high-end experts and more than 4,300 senior talents are constantly turning the gears of Taizhou Pharmaceutical's destiny every day, and new achievements in the field of medicine are born almost every week. In 2023, the scale of Taizhou's big health industry will reach more than 300 billion yuan. The finale of the high-profile CCTV financial program "Gold Medal New Brand" focused on the famous health city - Taizhou, Jiangsu, and paid a special visit to Yangtze River Pharmaceutical Group, an outstanding representative of the local health industry, which attracted attention from all walks of life.

CCTV's "Gold Medal New Brand" visited Yangtze River Pharmaceutical Group to witness the modern butterfly changes of traditional Chinese medicine

It is understood that in recent years, Yangtze River Pharmaceutical Group has continuously increased its investment in the innovation and development of the big health industry and scientific research, accelerated the layout of the health industry, and continued to build a Chinese pharmaceutical and health brand with global influence in the pursuit of high quality. At present, Yangtze River Pharmaceutical Group has hundreds of health products including Lanqin oral liquid, gastric su granules, astragalus essence and other hundreds of health products are exported to dozens of countries and regions around the world, such as United States, Russia, Singapore and Thailand. The visit of CCTV's "Gold Medal New Brand" not only made the audience feel the firm protection of Yangtze River Pharmaceutical Group's traditional Chinese medicine cultural inheritance, but also immersed themselves in the visual feast of modern Chinese medicine production.

From source to production

Technology empowers the whole process of quality control and leads the modernization of traditional Chinese medicine

In the program, the first to come to the Yangtze River Pharmaceutical Group Longfengtang Traditional Chinese Medicine Specimen Exhibition Hall, the host and guests personally experienced the handmade "Chinese medicine mosquito repellent sachet", found the required medicinal materials in hundreds of Chinese herbal medicines, grabbed the medicine, weighed, grinded... The details are true, and the "old objects" of the Chinese medicine shop that have only been seen in film and television dramas have been rejuvenated in the warm hands of the guests. Based on the culture of traditional Chinese medicine, Yangtze River Pharmaceutical Group is well aware that "good medicinal materials are good medicines", and high-quality Chinese medicinal materials are the cornerstone of the development of the Chinese medicine industry. Therefore, starting from the source, the group has established standardized planting bases for Chinese herbal medicines such as gardenia, organic astragalus, bergamot and cork in authentic Chinese herbal medicine production areas or high-quality main production areas across the country, and applied the self-developed "traceability system for the whole process of Chinese herbal medicine production" to the base management, so as to further control the source planting and realize that the source of Chinese herbal medicines can be checked, the quality can be controlled, the destination can be traced, and the responsibility can be investigated.

CCTV's "Gold Medal New Brand" visited Yangtze River Pharmaceutical Group to witness the modern butterfly changes of traditional Chinese medicine

Following the footsteps of the visit of "Gold Medal New Brand", the program went deep into the traditional Chinese medicine preparation workshop of Longfengtang of Yangtze River Pharmaceutical Group, presenting the audience with a picture of modern production and intelligent management. High-quality development is the primary task of building a modern socialist country in an all-round way. As a pilot enterprise of high-tech industry standardization of the Standardization Administration of the People's Republic of China, Yangtze River Pharmaceutical Group thoroughly implements the innovation-driven development strategy, focuses on cultivating new quality productivity, empowers the whole process of quality control with science and technology, and realizes standardization, intelligence and precision in production, packaging, warehousing and transportation, so as to achieve lean production and improve both quality and efficiency.

CCTV's "Gold Medal New Brand" visited Yangtze River Pharmaceutical Group to witness the modern butterfly changes of traditional Chinese medicine

In the intelligent production line, Yangtze River Pharmaceutical Group can accurately control the environmental data required for each step through accurate parameter setting and electronic recording, and the seamless connection between the processes of the production line has also increased the production efficiency by 28% and the output by 43%. On July 10, 2024, the "Longfengtang Traditional Chinese Medicine Whole Industry Chain Industrial Internet Platform" declared by Jiangsu Longfengtang Traditional Chinese Medicine Co., Ltd. of Yangtze River Pharmaceutical Group was successfully selected as the 2024 Jiangsu Province 5G Factory and Industrial Internet Platform. At the same time, in 2023, Yangtze River Pharmaceutical Group successfully passed the acceptance of the "National High-tech Industry Standardization Pilot Project for Intelligent Manufacturing of Traditional Chinese Medicine Process" of the National Standards Committee, creating the first national standardization pilot in the field of intelligent manufacturing of traditional Chinese medicine in Jiangsu Province; Guangzhou Hairui Pharmaceutical Co., Ltd., a subordinate of Guangzhou Hairui Pharmaceutical Co., Ltd., uses intelligent methods to realize the timely visualization of inventory data and precise control of the storage environment, and has been selected as an excellent scene of national intelligent manufacturing.

Yangtze River Pharmaceutical Group has always adhered to innovation-driven high-quality development, while strictly implementing international industry norms such as GMP/GSP, it has successively integrated international standards such as quality/environment/occupational health and safety management, measurement management, and laboratory accreditation, and gradually established an extraordinary quality management model of "from the inside out" to build a solid line of defense for quality and safety.

Maintain integrity and innovate multi-dimensional layout to promote the prosperity and development of traditional Chinese medicine

In the grand blueprint of Chinese-style modernization, education, science and technology, and talents are the basic and strategic support for Chinese-style modernization. The Third Plenary Session of the CPC Central Committee proposed that it is necessary to thoroughly implement the strategy of rejuvenating the country through science and education, the strategy of strengthening the country with talents, and the strategy of innovation-driven development, and promote the integrated reform of the system and mechanism of education, science and technology, and talents. As a pioneer in the inheritance, innovation and development of traditional Chinese medicine, Yangtze River Pharmaceutical Group actively responds to the call of the times and has always been at the forefront of the deep integration of industry, education and research.

In 2023, the "National Key Laboratory of High-end Preparations for Overcoming Drug Delivery Barriers" jointly reorganized with Fudan University will be put into operation, and China Pharmaceutical University will explore the construction of an integrated education center for studying abroad, production and education, so as to jointly promote the deep integration of academic research, industrial practice and talent cultivation. This series of measures not only accelerates the transformation efficiency of scientific and technological achievements, but also provides a steady stream of talents and technical support for the high-quality development of the pharmaceutical industry, fully demonstrating the responsibility and action of Yangtze River Pharmaceutical Group in promoting the modernization of traditional Chinese medicine.

The traditional Chinese medicine industry is blooming in the field of health with unprecedented vitality. In this context, Yangtze River Pharmaceutical Group will continue to adhere to the original intention of integrity and innovation of traditional Chinese medicine, let traditional Chinese medicine, a national treasure, shine more brightly in the new era, and at the same time, embrace modern science and technology with a more open attitude, develop new quality productivity of the traditional Chinese medicine industry according to local conditions, continue to accelerate the modernization process of traditional Chinese medicine, and make important contributions to the realization of the strategic goal of healthy China.

Read on